Related references
Note: Only part of the references are listed.Ligand activation of peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) inhibits cell growth in a mouse mammary gland cancer cell line
Jennifer E. Foreman et al.
CANCER LETTERS (2010)
Metabolic and nonmetabolic regulatory functions of peroxisome proliferator-activated receptor β
Paul A. Grimaldi
CURRENT OPINION IN LIPIDOLOGY (2010)
A Proposed Method of Logarithmic Transformation of Optical Coherence Tomography Data for Use in Clinical Research
Frederick L. Ferris et al.
OPHTHALMOLOGY (2010)
Comparison of small n statistical tests of differential expression applied to microarrays
Carl Murie et al.
BMC BIOINFORMATICS (2009)
Both the Peroxisome Proliferator-Activated Receptor δ Agonist, GW0742, and Ezetimibe Promote Reverse Cholesterol Transport in Mice by Reducing Intestinal Reabsorption of HDL-Derived Cholesterol
Francois Briand et al.
CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2009)
Targeted Genetic Disruption of Peroxisome Proliferator-Activated Receptor-δ and Colonic Tumorigenesis
Xiangsheng Zuo et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
Regulation of Peroxisome Proliferator-Activated Receptor-β/δ by the APC/β-CATENIN Pathway and Nonsteroidal Antiinflammatory Drugs
Jennifer E. Foreman et al.
MOLECULAR CARCINOGENESIS (2009)
Quantitative expression patterns of peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) protein in mice
Elizabeth E. Girroir et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
AMPK and PPARδ Agonists are exercise mimetics
Vihang A. Narkar et al.
CELL (2008)
Role of peroxisome-proliferator-activated receptor β/δ (PPARβ/δ) in gastrointestinal tract function and disease
Jeffrey M. Peters et al.
CLINICAL SCIENCE (2008)
RNA interference against peroxisome proliferator-activated receptor δ gene promotes proliferation of human colorectal cancer cells
L. Yang et al.
DISEASES OF THE COLON & RECTUM (2008)
The high affinity peroxisome proliferator-activated receptor-gamma agonist RS5444 inhibits both initiation and progression of colon tumors in azoxymethane-treated mice
Weidong Su et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
A Genecentric Human Protein Atlas for Expression Profiles Based on Antibodies
Lisa Berglund et al.
MOLECULAR & CELLULAR PROTEOMICS (2008)
Nonsteroidal Anti-Inflammatory Drugs Induced Endothelial Apoptosis by Perturbing Peroxisome Proliferator-Activated Receptor-δ Transcriptional Pathway
Jun-Yang Liou et al.
MOLECULAR PHARMACOLOGY (2008)
Ligand activation of peroxisome proliferator-activated receptor-beta/delta (PPAR beta/delta) and inhibition of cyclooxygenase 2 (COX2) attenuate colon carcinogenesis through independent signaling mechanisms
Holly E. Hollingshead et al.
CARCINOGENESIS (2008)
Peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) ligands do not potentiate growth of human cancer cell lines
Holly E. Hollingshead et al.
CARCINOGENESIS (2007)
Nonsteroidal anti-inflammatory drugs induce colorectal cancer cell apoptosis by suppressing 14-3-3ε
Jun-Yang Liou et al.
CANCER RESEARCH (2007)
Triglyceride:: High-density lipoprotein cholesterol effects in healthy subjects administered a peroxisome proliferator activated receptor δ agonist
Dennis L. Sprecher et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
Crosstalk between peroxisome proliferator-activated receptor δ and VEGF stimulates cancer progression
Dingzhi Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Protection of endothelial survival by peroxisome proliferator-activated receptor-δ mediated 14-3-3 upregulation
Jun-Yang Liou et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
Ligand activation of peroxisome proliferator-activated receptor β inhibits colon carcinogenesis
HE Marin et al.
CANCER RESEARCH (2006)
PPARδ regulates glucose metabolism and insulin sensitivity
CH Lee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
NO-donating aspirin isomers downregulate peroxisome proliferator-activated receptor (PPAR)δ expression in APCmin/+ mice proportionally to their tumor inhibitory effect:: Implications for the role of PPARδ in carcinogenesis
N Ouyang et al.
CARCINOGENESIS (2006)
Clonogenic assay of cells in vitro
Nicolaas A. P. Franken et al.
NATURE PROTOCOLS (2006)
The role of peroxisome proliferator-activated receptor-beta/delta in epithelial cell growth and differentiation
AD Burdick et al.
CELLULAR SIGNALLING (2006)
A human protein atlas for normal and cancer tissues based on antibody proteomics
M Uhlén et al.
MOLECULAR & CELLULAR PROTEOMICS (2005)
Generation of a unique strain of multiple intestinal neoplasia (Apc+/Min-FCCC) mice with significantly increased numbers of colorectal adenomas
HS Cooper et al.
MOLECULAR CARCINOGENESIS (2005)
Peroxisome proliferator-activated receptor expression and activation in normal human colonic epithelial cells and tubular adenomas
MW Matthiessen et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2005)
The Wnt/β-catenin signaling pathway targets PPARγ activity in colon cancer cells
EÅ Jansson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Peroxisome proliferator-activated receptor-δ attenuates colon carcinogenesis
FS Harman et al.
NATURE MEDICINE (2004)
The 15-lipoxygenase-1 product 13-S-hydroxyoctadecadienoic acid down-regulates PPAR-δ to induce apoptosis in colorectal cancer cells
I Shureiqi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Changes in the expression of the peroxisome proliferator-activated receptor γ gene in the colonic polyps and colonic mucosa of acromegalic patients
F Bogazzi et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
Minireview: Lipid metabolism, metabolic diseases, and peroxisome proliferator-activated receptors
CH Lee et al.
ENDOCRINOLOGY (2003)
Peroxisome proliferator-activated receptor γ ligands suppress colon carcinogenesis induced by azoxymethane in mice
E Osawa et al.
GASTROENTEROLOGY (2003)
Dose-dependent suppression of hyperlipidemia and intestinal polyp formation in Min mice by pioglitazone, a PPAR gamma ligand
N Niho et al.
CANCER SCIENCE (2003)
Peroxisome proliferator activated receptor γ expression is reduced in the colonic mucosa of acromegalic patients.
F Bogazzi et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2002)
Rat PPARs: Quantitative analysis in adult rat tissues and regulation in fasting and refeeding
P Escher et al.
ENDOCRINOLOGY (2001)
A selective peroxisome proliferator-activated receptor δ agonist promotes reverse cholesterol transport
WR Oliver et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Genetic disruption of PPARδ decreases the tumorigenicity of human colon cancer cells
BH Park et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Activation of PPARδ alters lipid metabolism in db/db mice
MD Leibowitz et al.
FEBS LETTERS (2000)